CMOs urge trusts to continue recruiting for RECOVERY trial
Trusts should aim to recruit at least 60% of eligible COVID-19 patients into trials
Read More
Tag: CMOs
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
